{"Title": ["7 Great Biotech Stocks to Buy and Hold Now", "7 Cheap Stocks to Buy With Great Potential", "Why ImmunoGen Stock Jumped Today", "7 Biotech Stocks Wall Street Says Will Double or More", "Why ImmunoGen Stock Jumped Today", "Health Care Sector Update for 05/01/2020: IMGN,SGEN,MOH,MGLN,ATHX", "Immunogen Inc (IMGN) Q1 2020 Earnings Call Transcript", "Why ImmunoGen Shares Are Sinking Today", "7 Great Biotech Stocks to Buy and Hold Now", "ImmunoGen Beats Expectations and Fuels Optimism for Its Lead Drug Candidate", "What's Behind ImmunoGen's Blowout Q4 Results", "Health Care Sector Update for 02/14/2020: DXCM,IMGN,PLSE", "Immunogen Inc (IMGN) Q4 2019 Earnings Call Transcript", "Stock Alert: ImmunoGen (IMGN)", "Health Care Sector Update for 02/14/2020: PLSE, SLGL, IMGN, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 12/17/2019: GSK,IBIO,IMGN,CFRX", "Health Care Sector Update for 02/14/2020: DCPH,DXCM,IMGN,PLSE", "Health Care Sector Update for 12/17/2019: PTI, IMGN, BHVN, JNJ, PFE, ABT, MRK, AMGN", "Here\u2019s Why ImmunoGen Jumped 12.4% Today", "Why ImmunoGen Stock Is Crushing It Today", "ImmunoGen Stretches Its Cash in Q3, Banking on Another Chance for Its Ovarian Cancer Drug", "Immunogen Inc (IMGN) Q3 2019 Earnings Call Transcript", "Week Ahead In Pharma: 9 Stocks To Watch (AVXL, GMAB, ARAV\u2026)", "Immunogen Inc (IMGN) Q2 2019 Earnings Call Transcript", "Health Care Sector Update for 12/17/2019: IBIO,IMGN,CFRX", "Health Care Sector Update for 08/02/2019: APHA, TNDM, IMGN, JNJ, PFE, ABT, MRK, AMGN", "Why The Children's Place, Agilent Technologies, and Immunogen Slumped Today", "Health Care Sector Update for 05/15/2019: ABBV,ACB,ACB.TO,ECOR,IMGN", "Mid-Afternoon Market Update: Global Eagle Entertainment Surges After Q1 Results; ImmunoGen Shares Tumble", "Health Care Sector Update for 05/15/2019: ECOR, ACB, IMGN", "Mid-Day Market Update: Dow Rises Over 100 Points; Sunworks Falls Following Q1 Results", "Mid-Morning Market Update: Markets Mostly Lower; Macy's Earnings Top Estimates", "What You'll Want to Know About ImmunoGen's Q2 Results", "Immunogen Inc (IMGN) Q1 2019 Earnings Call Transcript", "Health Care Sector Update for 05/03/2019: XRAY, AZN, IMGN, JNJ, PFE, ABT, MRK, AMGN", "Notable Wednesday Option Activity: IMGN, FSLR, APC", "ImmunoGen Stock Is in Trouble Going Into Earnings", "ImmunoGen Stock Is in Trouble Going Into Earnings", "Noteworthy Friday Option Activity: IMGN, SPWR, MMM", "Noteworthy Friday Option Activity: IMGN, SPWR, MMM", "Health Care Sector Update for 05/15/2019: IMGN, A, ACBI, JNJ, PFE, ABT, MRK, AMGN", "Here's Why ImmunoGen Tumbled 43% in March", "Options Traders Expect Huge Moves in ImmunoGen (IMGN) Stock", "ImmunoGen (IMGN) Down 50.2% Since Last Earnings Report: Can It Rebound?", "Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More", "Immunogen Ovarian Cancer Drug Fails in Phase III, Stock Sinks", "After Hours Most Active for Mar 4, 2019 : LTHM, LLY, ATVI, BAC, S, OHI, GE, GILD, CMCSA, IMGN, AAPL, SGMS", "Why ImmunoGen Stock Is Crashing Today", "Here's Why ImmunoGen Tumbled 43% in March", "Mid-Morning Market Update: Markets Open Higher; Foot Locker Beats Q4 Estimates", "Health Care Sector Update for 03/01/2019: IMGN, MRSN, PBYI, JNJ, PFE, MRK, ABT, AMGN", "Pre-Market Most Active for Mar 1, 2019 : IMGN, GRPN, GPS, FL, AMD, SQQQ, GE, ERIC, QQQ, CHK, VIPS, NIO", "ImmunoGen drug fails cancer study, shares slide 40 pct", "Health Care Sector Update for 03/01/2019: BIO,MRSN,PBYI,IMGN", "Mid-Afternoon Market Update: Crude Oil Down 2.5%; Nutanix Shares Plunge On Weak Forecast", "Health Care Sector Update for 03/01/2019: MRSN,PBYI,IMGN", "Mid-Day Market Update: Puma Biotechnology Climbs Following Strong Q4 Results; Intrexon Shares Slide", "ImmunoGen Still Waiting to Take Its Leap \"Forward\"", "ImmunoGen (IMGN) Beats on Earnings & Sales in Q4, Shares Up", "Options Traders Expect Huge Moves in ImmunoGen (IMGN) Stock", "ImmunoGen (IMGN) Q4 2018 Earnings Conference Call Transcript", "ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates", "Earnings Reaction History: ImmunoGen, Inc., 27.3% Follow-Through Indicator, 5.7% Sensitive", "Noteworthy Friday Option Activity: VICR, IMGN, TTD", "Why ImmunoGen Tumbled 20.3% Today", "ImmunoGen Still Waiting to Take Its Leap \"Forward\"", "Earnings Preview: ImmunoGen (IMGN) Q4 Earnings Expected to Decline", "Notable Tuesday Option Activity: MSFT, EGHT, IMGN", "After Hours Most Active for Jan 8, 2019 : INFN, IMGN, CMCSA, JD, MSFT, CELG", "Why ImmunoGen Jumped Today", "After Hours Most Active for Jan 2, 2019 : IMGN, MSFT, FOLD, QQQ, EBAY, XOG", "Why ImmunoGen Shot Up 13% Today", "Why ImmunoGen Jumped Almost 14% Today", "ImmunoGen (IMGN) Down 7.2% Since Last Earnings Report: Can It Rebound?", "Apple Falls, UnitedHealth Gains, and More Morning Movers", "ImmunoGen Waits to Leap \"Forward\"", "Here's Why ImmunoGen Shares Lost 42.7% in October", "Here's Why ImmunoGen Closed Almost 12% Up on Wednesday", "ImmunoGen (IMGN) Beats on Earnings in Q3, Lowers Guidance", "Immunogen Inc (IMGN) Q3 2018 Earnings Conference Call Transcript", "Roche's Kadcyla Halves Death Risk in Breast Cancer Study", "ImmunoGen (IMGN) Q3 Earnings Preview: What to Look Out For", "Here's Why ImmunoGen Fell Today", "Notable Tuesday Option Activity: DWDP, IP, IMGN", "Are Options Traders Betting on a Big Move in ImmunoGen (IMGN) Stock?", "Why ImmunoGen Inc. Dropped 8% Today", "Why ImmunoGen, Inc. Fell 10.6% on Thursday", "Health Care Sector Update for 09/07/2018: IMGN,NVUS,ADXS", "Earnings Reaction History: ImmunoGen, Inc., 27.3% Follow-Through Indicator, 5.4% Sensitive", "ImmunoGen (IMGN) Q3 Earnings Preview: What to Look Out For", "ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates", "ImmunoGen (IMGN) Q2 Loss Wider, Revenues Miss", "What's in Store for ImmunoGen (IMGN) This Earnings Season?", "Here's Why ImmunoGen Fell 15.1% in June", "Interesting IMGN Put And Call Options For August 17th", "Health Care Sector Update for 09/07/2018: OPK,IMGN,NVUS,ADXS", "ImmunoGen's Lead Candidate Gets Fast Track for Ovarian Cancer", "The Brian Bolan Show!", "Health Care Sector Update for 06/07/2018: MRK, ASND, PTI, IMGN, MDGL", "Here's Why ImmunoGen Inc. Fell 9.2% Today", "Health Care Sector Update for 06/07/2018: AGN,IMGN,MRK,PTI,VRX,VRX.TO", "Health Care Sector Update for 06/07/2018: IMGN,MRK,PTI,VRX,VRX.TO", "Why Is ImmunoGen (IMGN) Up 4.2% Since Its Last Earnings Report?", "Better Buy: Exelixis, Inc. vs. Immunogen, Inc.", "ImmunoGen Presses Forward", "ImmunoGen (IMGN) Q1 Loss Wider Than Expected, Revenues Beat", "ImmunoGen (IMGN) Q1 Loss Wider, Revenues Beat", "What's in Store for ImmunoGen (IMGN) This Earnings Season?", "Why ImmunoGen, Inc. Stock Is on the Rise Today", "Are Options Traders Betting on a Big Move in ImmunoGen (IMGN) Stock?", "Fast Pipeline Progress Pushes ImmunoGen Above 150% in a Year", "Why ImmunoGen Jumped Higher Today", "2 Longs & 2 Shorts to Watch", "Commit To Buy ImmunoGen At $8, Earn 31.6% Annualized Using Options", "First Week of October 19th Options Trading For ImmunoGen (IMGN)", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth?", "ImmunoGen Moves One Foot Forward", "What's Behind ImmunoGen Inc.'s Brief Dip on Tuesday?", "What Knocked ImmunoGen, Inc. Down 15% on Tuesday?", "Why ImmunoGen Jumped Higher Today", "ImmunoGen (IMGN) Q4 Loss Wider, Revenues Rise Y/Y", "Earnings Reaction History: ImmunoGen, Inc., 20.0% Follow-Through Indicator, 5.0% Sensitive", "Is a Surprise Coming for ImmunoGen (IMGN) This Earnings Season?", "Is a Beat in the Cards for ImmunoGen (IMGN) in Q4 Earnings?", "Why ImmunoGen Inc. Pulled Back Today", "ImmunoGen (IMGN) Soars: Stock Adds 10.3% in Session", "ImmunoGen (IMGN) Q4 Loss Wider Than Expected, Revenues Grow", "Why ImmunoGen, Inc. Jumped on Tuesday and Is Holding Steady", "ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632", "ImmunoGen (IMGN) Soars Above 200% This Year: Here's Why", "Why ImmunoGen, Inc. Jumped Higher Today", "Health Care Sector Update for 12/11/2017: VSTM, MRK, IONS, GILD, IMGN, JUNO, CELG, REGN, BIVV", "5 Cheap Biotech Stocks to Snag on the Bounce", "Why Is ImmunoGen (IMGN) Stock Up More Than 150% This Year?", "Here's What's Lifting ImmunoGen, Inc. Shares Today", "Jazz Pharmaceuticals (JAZZ) Q3 Earnings Top, 2017 View Cut", "The Big Reason ImmunoGen, Inc. Shed 24% of Its Value in October", "ImmunoGen (IMGN) Q3 Loss Wider Than Expected, Cash View Up", "Pre-Market Most Active for Nov 3, 2017 : P, AAPL, TEVA, SBUX, BAC, CBL, IMGN, QQQ, VALE, TVIX, TWTR, MU", "ImmunoGen (IMGN) Reports Wider-than-Expected Q3 Loss", "Should You Buy ImmunoGen (IMGN) Ahead of Earnings?", "Why ImmunoGen, Inc. Got Burned into ASH Today", "ImmunoGen, Inc. Moves Forward", "Can ImmunoGen's Key Pipeline Cancer Candidate Drive Growth?", "ImmunoGen to Push Leukemia Candidate into Phase I Trial", "Health Care Sector Update for 10/16/2017: IMGN", "Pre-Market Most Active for Oct 6, 2017 : NLY, SNCR, IMGN, BAC, MNKD, QQQ, ERIC, TVIX, AZN, BTI, SNY, BABA", "Why ImmunoGen, Inc. Dropped Today", "2 Stocks Move in After-Hours Trading", "Better Buy: Exelixis, Inc. vs. Immunogen, Inc.", "Is a Beat in the Cards for ImmunoGen (IMGN) in Q3 Earnings?", "Why Shares of ImmunoGen, Inc. Sank Today", "Tuesday Sector Laggards: Electric Utilities, Biotechnology Stocks", "5 Key Things You Should Watch With Jazz Pharmaceuticals", "Bull of the Day: Jazz Pharmaceuticals (JAZZ)", "ImmunoGen (IMGN) Up 17.7% Since Earnings Report: Can It Continue?", "Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule", "ImmunoGen (IMGN) in Focus: Stock Moves 17.3% Higher", "Is ImmunoGen Running Out of Steam, or Taking a Breather?", "Why Shares of ImmunoGen, Inc. Sank Today", "Health Care Sector Update for 08/29/2017: JNJ, PFE, ABT, MRK, AMGN, IMGN, ETRM", "Why Movado Group, Catalent, and ImmunoGen Jumped Today", "Health Care Sector Update for 08/29/2017: IMGN,JAZZ,JUNO,ACOR", "Why ImmunoGen, Inc. Jumped Higher Today", "After Hours Most Active for Aug 24, 2017 : MSFT, LYG, CSCO, MU, BAC, HPQ, BABA, TGT, MYL, IMGN, ESV, ACWI", "Why Investors Bid Immunogen Inc. Up Almost 12% Today", "Stocks Snap 3-Day Losing Streak", "Friday's ETF Movers: XBI, XME", "Friday Sector Leaders: Computer Peripherals, Biotechnology Stocks", "Here's What Pushed ImmunoGen, Inc. Stock 16.5% Lower in July", "ImmunoGen, Inc. Earnings: What Goes Up, Must Come Down", "ImmunoGen (IMGN) Q2 Loss Narrows, Sales & Cash Outlook Up", "Mid-Day Market Update: Boston Beer Surges On Earnings Beat; Destination Maternity Shares Slide", "What's a Retailer To Do?", "Stocks Snap 3-Day Losing Streak", "Friday's ETF Movers: XBI, XME", "Friday Sector Leaders: Computer Peripherals, Biotechnology Stocks", "Monday Sector Leaders: Biotechnology, Drugs", "Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?", "Can ImmunoGen's Lead Pipeline Cancer Candidate Boost Growth?", "Here's Why ImmunoGen, Inc. Shares Exploded 54% Higher in June", "ImmunoGen (IMGN) Reports Narrower-than-Expected Q2 Loss", "Why Shares of ImmunoGen Inc. Shot Up Today", "Four Stocks Breaking Out", "Why ImmunoGen, Inc. Jumped Higher Today", "Monday Sector Leaders: Biotechnology, Drugs", "Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?", "Can ImmunoGen's Lead Pipeline Cancer Candidate Boost Growth?", "Why ImmunoGen, Inc. Jumped Higher for the Second Day in a Row", "Health Care Sector Update for 07/06/2017: IMGN,BGNE,CELG,EGLT", "Why ImmunoGen, Inc. Jumped Higher on Monday", "Health Care Sector Update for 06/26/2017: IMGN,SRNE,NEOT", "5 Best Biotech Stocks of 2017 So Far", "Why ImmunoGen, Inc. Jumped Higher Today", "Mid-Afternoon Market Update: Fang Drops After Q1 Results; Invivo Therapeutics Shares Surge", "Tuesday Sector Leaders: Biotechnology, Drugs", "Why Is ImmunoGen (IMGN) Stock Up 131% This Year?", "Mid-Afternoon Market Update: Crude Oil Down 3%; La-Z-Boy Shares Gain On Earnings Beat", "ImmunoGen (IMGN) Up 21.2% Since Earnings Report: Can It Continue?", "3 Stocks With Exelixis-Like Return Potential", "After Hours Most Active for May 24, 2017 : INTC, PFE, WY, F, WIN, MRO, OAS, JCP, MSFT, IMGN, BRCD, EBAY", "ImmunoGen (IMGN) Shows Strength: Stock Up 14.2% Higher", "Mid-Morning Market Update: Markets Mostly Higher; Wal-Mart Profit Tops Estimates", "Why ImmunoGen, Inc. Jumped Higher Today", "Why ImmunoGen, Inc. Stock Is Flying High Today", "Short on Investing Cash? These $5 Stocks Are Up Big in 2017", "ImmunoGen (IMGN) Posts Narrower-than-Expected Loss in Q1", "ImmunoGen (IMGN) Reports Narrower-than-Expected Loss", "What's in the Cards for Allergan (AGN) this Earnings Season?", "Why ImmunoGen (IMGN) Might Surprise This Earnings Season", "Puma Biotechnology (PBYI) Q1 Earnings: Stock to Disappoint?", "Jazz Pharma (JAZZ) Q1 Earnings: Stock Likely to Disappoint?", "What's in the Cards for Inovio (INO) This Earnings Season?", "ImmunoGen, Inc. Begins FORWARD I, Investors Wait", "Is ImmunoGen (IMGN) Poised for a Beat this Earnings Season?", "Can Conatus Pharma (CNAT) Deliver a Beat in Q1 Earnings?", "When Will ImmunoGen, Inc. Finally Start Making Money?", "Why ImmunoGen, Inc. Jumped Higher Today", "Why ImmunoGen, Inc. Shot Up Today", "Why ImmunoGen, Inc. Stock Jumped Higher Today", "ImmunoGen (IMGN) Up 47.2% Since Earnings Report: Can It Continue?", "Kite Pharma (KITE) Q1 Earnings: Is a Surprise in the Cards?", "Mid-Morning Market Update: Markets Open Higher; Dollar General Beats Q4 Expectations", "Here's Why ImmunoGen, Inc. Skyrocketed 45% in February", "3 Charts That Show the Potential Risks and Rewards for Immunogen, Inc. Stock", "Monday Sector Leaders: Music & Electronics Stores, Biotechnology Stocks", "Why ImmunoGen, Inc. Skyrocketed Higher Today", "ImmunoGen, Inc.: Waiting to Move FORWARD", "ImmunoGen Posts Wider-than-Expected Loss; Sales Down Y/Y", "Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates", "Earnings Reaction History: ImmunoGen, Inc., 33.3% Follow-Through Indicator, 5.7% Sensitive", "What's in Store for ImmunoGen (IMGN) this Earnings Season?", "Immunogen Doses First Patient in Ovarian Cancer Drug Study", "Wednesday Sector Leaders: Biotechnology, Music & Electronics Stores", "Why ImmnoGen, Inc. Jumped Higher Today", "Why ImmunoGen, Inc. Shares Rocketed Higher by 29%", "ImmunoGen: Phase I Data on Ovarian Cancer Drug Published", "ImmunoGen (IMGN) Reports Wider-than-Expected Loss", "Earnings Reaction History: ImmunoGen, Inc., 33.3% Follow-Through Indicator, 5.7% Sensitive", "What's in Store for ImmunoGen (IMGN) this Earnings Season?", "Immunogen Doses First Patient in Ovarian Cancer Drug Study", "Wednesday Sector Leaders: Biotechnology, Music & Electronics Stores", "AmerisourceBergen (ABC) Q3 Earnings: Will It Disappoint?", "Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN", "Big Changes to BioShares Biotech ETFs: Who's In, Who's Out?", "GlaxoSmithKline (GSK) Q3 Earnings: What's in the Cards?", "McKesson (MCK) Q2 Earnings: Stock Likely to Disappoint?", "Express Scripts (ESRX) Q3 Earnings: What's in the Cards?", "Alexion (ALXN) Q3 Earnings: Can the Stock Pull a Surprise?", "Novartis (NVS) Q3 Earnings: Stock to Beat Estimates Again?", "Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?", "ImmunoGen to Cut Workforce by 17% for Long Term Growth", "What's Ahead for ImmunoGen (IMGN) This Earnings Season?", "ImmunoGen, Inc. Gets the FDA Green Light (for Its Trial Design)", "These 2 Lingering Issues Pushed ImmunoGen, Inc. Lower by 10% in July", "ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4", "Will ImmunoGen (IMGN) Disappoint Again on Q4 Earnings?", "Why ImmunoGen, Inc. Bounded Higher Today", "ImmunoGen, Inc. Shed 45% of Its Value in June -- Can It Recover?", "Why is ImmunoGen (IMGN) Stock Down Today?", "This Beaten-Down Biotech Could Return 1,500%+: Here\u2019s Why I Won\u2019t Buy It", "ImmunoGen, Inc. Gets the FDA Green Light (for Its Trial Design)", "These 2 Lingering Issues Pushed ImmunoGen, Inc. Lower by 10% in July", "ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4", "Will ImmunoGen (IMGN) Disappoint Again on Q4 Earnings?", "Why ImmunoGen, Inc. Bounded Higher Today", "ImmunoGen, Inc. Shed 45% of Its Value in June -- Can It Recover?", "Notable Friday Option Activity: MET, GS, IMGN", "Why ImmunoGen, Inc. Noted a Lower Price Today", "Moving FORWARD Sends ImmunoGen, Inc. Backwards in May", "ImmunoGen Announces Phase I Cohort Ovarian Cancer Data", "ImmunoGen (IMGN) Posts Wider-than-Expected Q3 Loss", "Mid-Morning Market Update: Markets Open Lower; Exxon Mobil Profit Tops Estimates", "ImmunoGen (IMGN) Posts Wider-than-Expected Q3 Loss", "Why ImmunoGen, Inc. Was Down Today (Hint: It Wasn't Earnings)", "Mid-Afternoon Market Update: NASDAQ Down Over 1%; SkyWest Shares Jump On Earnings Beat", "IMGN Makes Notable Cross Below Critical Moving Average", "The Zacks Analyst Blog Highlights: ALPS Medical Breakthroughs ETF, Anacor Pharmaceuticals, Dyax, Ultragenyx Pharmaceutical and ImmunoGen", "Mid-Morning Market Update: Markets Edge Higher; Deere Profit Tops Views", "Here's Why Immunomedics' Stock Skyrocketed Higher in October", "Commit To Buy ImmunoGen At $9, Earn 12.4% Annualized Using Options", "ImmunoGen, Inc. Pushes Its Pipeline Forward", "Why BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc, and ImmunoGen, Inc. Got Clobbered Today", "ImmunoGen's (IMGN) Q1FY16 Loss Wider-than-Expected", "What Awaits ImmunoGen (IMGN) This Earnings Season?", "Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views", "Why ImmunoGen Fell 15% Today", "Friday's ETF with Unusual Volume: XBI", "Why ImmunoGen Shares Are Falling Today", "Why ImmunoGen's Shares Soared 13% Higher Today", "ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q1", "Why Shares of ImmunoGen Inc Were Up Big Today", "ImmunoGen Inc: Finally Targeting Strong Returns?", "ImmunoGen: Back to a Development-Stage Biotech", "ImmunoGen Is Climbing Higher... Again", "Monday's ETF Movers: XBI, GDX", "ImmunoGen, Inc.'s Shares Jumped Another 15% Today", "5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary", "Thursday's ETF Movers: XBI, GXC", "Why Shares of ImmunoGen Inc Were Up Big Today", "ImmunoGen Inc: Finally Targeting Strong Returns?", "ImmunoGen: Back to a Development-Stage Biotech", "ImmunoGen Is Climbing Higher... Again", "Monday's ETF Movers: XBI, GDX", "Will Alexion's (ALXN) Soliris Drive Q1 Earnings Beat? - Analyst Blog", "Strength Seen in ImmunoGen (IMGN): Stock Soars 71.9% - Tale of the Tape", "ImmunoGen Surges on Positive Ovarian Cancer Study Data - Analyst Blog", "Why ImmunoGen Inc.'s Stock Soared Today", "Why ImmunoGen Inc. Shares Tumbled Today", "Health Care Sector Update for 04/24/2015: IMGN, GWPH, AZN", "Will Pharmaceutical Sales Drive J&J (JNJ) Earnings Again? - Analyst Blog", "1 Small-Cap Biotech Stock to Buy and Hold For the Next 10 Years", "5 Promising Biotech Stocks Under $10", "Is AbbVie (ABBV) Set to Top 1Q Earnings on Humira & HCV? - Analyst Blog", "Why ImmunoGen Inc. is Skyrocketing Today", "Why ImmunoGen Inc. is Soaring Higher Today", "Futures Cautious As Greece, Oil and Economic Calendar Weigh on Equities", "Pre-Market Most Active for Mar 23, 2015 : STO, GSK, GILD, AAPL, VRTX, IMGN, RDS/B, QQQ, FB, RDS/A, SDRL, NVS", "Health Care Sector Update for 03/23/2015: IMGN,CAPN,MEIP", "In Case You Missed It, Researchers May Have Discovered a New Method to Treat Cancer", "Why ImmunoGen, Inc. Shares Rocketed Higher By 25% in January", "ImmunoGen (IMGN) in Focus: Stock Rises 5.1% in Session - Tale of the Tape", "3 Value Stocks Near 52-Week Lows Worth Buying", "ImmunoGen/Roche's Kadcyla Fails in Study, Shares Plunge - Analyst Blog", "Pre-Market Most Active for Dec 19, 2014 : ALLY, BBRY, BP, AVNR, TNK, PBR, OREX, BHP, SDRL, QQQ, AAPL, IMGN", "Why ImmunoGen Inc. Stock Was Throttled", "Why ImmunoGen, Inc. Stock Plunged 13% in October", "ImmunoGen, Inc. Pushes Forward", "ImmunoGen, Inc. Gets Into the Black, Accounting Wise", "Why ImmunoGen, Inc. Stock Was Decimated in December", "3 Value Stocks Near 52-Week Lows Worth Buying", "ImmunoGen/Roche's Kadcyla Fails in Study, Shares Plunge - Analyst Blog", "Pre-Market Most Active for Dec 19, 2014 : ALLY, BBRY, BP, AVNR, TNK, PBR, OREX, BHP, SDRL, QQQ, AAPL, IMGN", "Why ImmunoGen Inc. Stock Was Throttled", "ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance - Analyst Blog", "3 Beaten-Down Stocks Worth Buying", "ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape", "3 Value Stocks Near 52-Week Lows Worth Buying", "First Week of IMGN November 22nd Options Trading", "Breast Cancer Occurs Most Often in These 5 States", "Why ImmunoGen, Inc. Stock Crashed 22% in 2014", "Synergy Pharmaceuticals (SGYP) Jumps: Stock Up 10.9% - Tale of the Tape", "Sector Update: Healthcare Shares Flat to Lower Pre-Market; ImmunoGen's Q3 Net Loss Widens From Year Prior", "Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape", "ImmunoGen (IMGN) Soars: Stock Up 8.8% - Tale of the Tape", "Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9% - Tale of the Tape", "ImmunoGen, Inc. (IMGN) in Focus: Stock Rallies 11% - Tale of the Tape", "Zogenix Shares Soar on Massachusetts Developments - Analyst Blog", "Wednesday Sector Leaders: Biotechnology, Rubber & Plastics", "Wednesday's ETF Movers: FBT, GDX", "Sector Update: Healthcares", "Pacira Prices Offering, Shares Soar - Analyst Blog", "ImmunoGen Up on Positive Pipeline Data - Analyst Blog", "Regulatory Update from Forest Labs - Analyst Blog", "ImmunoGen's Q2FY14 Earnings Surpass Expectations - Analyst Blog", "Sector Update: Healthcare Shares Flat Pre-Market; ImmunoGen up 4% on Q4 Results", "Sector Update: Healthcare", "Earnings Reaction History: ImmunoGen, Inc., 42.9% Follow-Through Indicator, 5.8% Sensitive", "Pharmacyclics (PCYC) Crumbles: Stock Falls by 7.7% - Tale of the Tape", "ImmunoGen Amends Lilly Agreement - Analyst Blog", "ImmunoGen Rises on Licensing Deal - Analyst Blog", "Sector Update: Healthcare Shares Mixed Pre-Market; Progenics Reports Better-Than-Expected Net Loss", "Sector Update: Healthcare", "ImmunoGen' Shares Fall on Trial Halt - Analyst Blog", "Mid-Afternoon Market Update: Marvell Rises on KKR Stake While Orbitz Gives Up Last Week's Gains", "Healthcare Stocks Mostly Retreat; ImmunoGen Falls More Than 20% After Shelving Influenza Drug Trial", "BioCryst Confirms Funding for BCX4430 - Analyst Blog", "ImmunoGen Amends Lilly Agreement - Analyst Blog", "ImmunoGen Rises on Licensing Deal - Analyst Blog", "Sector Update: Healthcare Shares Mixed Pre-Market; Progenics Reports Better-Than-Expected Net Loss", "ImmunoGen in Licensing Deals - Analyst Blog", "Sector Update: Healthcare Shares Flat to Higher; Immunogen up 6% on Licensing to Novartis", "Sector Update: Healthcare", "Sector Update: Healthcare", "Narrower-than-Expected Loss at ImmunoGen - Analyst Blog", "Company News for August 5, 2013 - Corporate Summary", "Sector Update: Healthcare Stocks Flat Pre-Market; ImmunoGen Hits New 52-Week High on Q2 Results", "Sector Update: Healthcare", "Trade the Earnings: ImmunoGen, Inc.", "GuruFocus Reports Dividend Growers: May 17-24", "Murray Stahl's $6.4 Billion Horizon Kinetics Sells Out Six Companies in First Quarter", "Sector Update: Biotechnology Stocks Showing The Way On NASDAQ", "Narrower-than-Expected Loss at ImmunoGen - Analyst Blog", "Company News for August 5, 2013 - Corporate Summary", "Sector Update: Healthcare Stocks Flat Pre-Market; ImmunoGen Hits New 52-Week High on Q2 Results", "Sector Update: Healthcare", "ImmunoGen Progresses with IMGN901 - Analyst Blog", "Wider Loss at ImmunoGen - Analyst Blog", "Pre-Market Earnings Report for January 25, 2013 : PG, HON, HAL, KMB, COV, WY, OSK, PB, MOG/A, IMGN, ACO, CMCO", "ImmunoGen Narrows Loss - Analyst Blog", "ImmunoGen to Focus on Pipeline - Analyst Blog", "Market Wrap for Friday, April 12: Stocks Record Modest Losses; Treasuries Surge and Precious Metals Plunge", "Roche Teams Up with Biocare - Analyst Blog", "FDA Approves Roche's Kadcyla - Analyst Blog", "ImmunoGen Progresses with IMGN901 - Analyst Blog", "Wider Loss at ImmunoGen - Analyst Blog", "Pre-Market Earnings Report for January 25, 2013 : PG, HON, HAL, KMB, COV, WY, OSK, PB, MOG/A, IMGN, ACO, CMCO", "ImmunoGen Narrows Loss - Analyst Blog"], "Elapsed Time": ["JUN 11, 2020", "MAY 27, 2020", "MAY 20, 2020", "MAY 19, 2020", "MAY 4, 2020", "MAY 1, 2020", "MAY 1, 2020", "FEB 18, 2020", "JUN 11, 2020", "FEB 14, 2020", "FEB 14, 2020", "FEB 14, 2020", "FEB 14, 2020", "FEB 14, 2020", "FEB 14, 2020", "DEC 17, 2019", "FEB 14, 2020", "DEC 17, 2019", "DEC 4, 2019", "NOV 5, 2019", "NOV 1, 2019", "NOV 1, 2019", "SEP 21, 2019", "AUG 6, 2019", "DEC 17, 2019", "AUG 2, 2019", "MAY 15, 2019", "MAY 15, 2019", "MAY 15, 2019", "MAY 15, 2019", "MAY 15, 2019", "MAY 15, 2019", "AUG 2, 2019", "MAY 3, 2019", "MAY 3, 2019", "MAY 1, 2019", "APR 15, 2019", "APR 15, 2019", "APR 12, 2019", "APR 12, 2019", "MAY 15, 2019", "APR 8, 2019", "MAR 12, 2019", "MAR 10, 2019", "MAR 6, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 1, 2019", "APR 8, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "FEB 12, 2019", "FEB 11, 2019", "FEB 11, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 8, 2019", "FEB 27, 2019", "FEB 4, 2019", "FEB 1, 2019", "JAN 29, 2019", "JAN 8, 2019", "JAN 7, 2019", "JAN 2, 2019", "DEC 26, 2018", "FEB 6, 2019", "DEC 2, 2018", "NOV 27, 2018", "NOV 9, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 5, 2018", "NOV 2, 2018", "DEC 6, 2018", "OCT 26, 2018", "OCT 22, 2018", "OCT 9, 2018", "OCT 8, 2018", "OCT 5, 2018", "OCT 4, 2018", "SEP 7, 2018", "NOV 2, 2018", "OCT 26, 2018", "JUL 30, 2018", "JUL 27, 2018", "JUL 25, 2018", "JUL 13, 2018", "JUL 2, 2018", "SEP 7, 2018", "JUN 19, 2018", "JUN 14, 2018", "JUN 7, 2018", "JUN 7, 2018", "JUN 7, 2018", "JUN 7, 2018", "JUN 4, 2018", "JUN 26, 2018", "MAY 8, 2018", "MAY 7, 2018", "MAY 4, 2018", "APR 30, 2018", "APR 27, 2018", "APR 18, 2018", "APR 2, 2018", "MAY 31, 2018", "MAR 14, 2018", "MAR 12, 2018", "FEB 23, 2018", "FEB 17, 2018", "FEB 14, 2018", "FEB 13, 2018", "FEB 13, 2018", "MAR 28, 2018", "FEB 12, 2018", "FEB 9, 2018", "FEB 9, 2018", "FEB 8, 2018", "FEB 5, 2018", "FEB 5, 2018", "FEB 1, 2018", "FEB 12, 2018", "JAN 11, 2018", "JAN 5, 2018", "DEC 29, 2017", "DEC 13, 2017", "DEC 11, 2017", "DEC 8, 2017", "NOV 27, 2017", "JAN 31, 2018", "NOV 8, 2017", "NOV 7, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 1, 2017", "NOV 9, 2017", "OCT 19, 2017", "OCT 17, 2017", "OCT 16, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 4, 2017", "SEP 30, 2017", "OCT 30, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 7, 2017", "SEP 5, 2017", "AUG 31, 2017", "AUG 30, 2017", "AUG 30, 2017", "SEP 16, 2017", "SEP 12, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 24, 2017", "AUG 30, 2017", "AUG 14, 2017", "AUG 11, 2017", "AUG 11, 2017", "AUG 2, 2017", "JUL 31, 2017", "JUL 31, 2017", "JUL 28, 2017", "AUG 16, 2017", "AUG 14, 2017", "AUG 11, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 21, 2017", "JUL 13, 2017", "JUL 10, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUL 6, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 25, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 15, 2017", "JUN 21, 2017", "JUN 7, 2017", "JUN 5, 2017", "MAY 24, 2017", "MAY 19, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 15, 2017", "JUN 12, 2017", "MAY 8, 2017", "MAY 5, 2017", "MAY 4, 2017", "MAY 4, 2017", "MAY 3, 2017", "MAY 3, 2017", "MAY 3, 2017", "MAY 10, 2017", "MAY 2, 2017", "MAY 2, 2017", "APR 27, 2017", "APR 20, 2017", "APR 19, 2017", "APR 13, 2017", "MAR 20, 2017", "MAY 3, 2017", "MAR 16, 2017", "MAR 9, 2017", "MAR 4, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 21, 2017", "FEB 20, 2017", "MAR 17, 2017", "FEB 17, 2017", "FEB 13, 2017", "JAN 27, 2017", "JAN 4, 2017", "JAN 4, 2017", "DEC 30, 2016", "DEC 29, 2016", "FEB 17, 2017", "FEB 17, 2017", "FEB 13, 2017", "JAN 27, 2017", "JAN 4, 2017", "OCT 27, 2016", "OCT 27, 2016", "DEC 19, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 3, 2016", "OCT 24, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 5, 2016", "AUG 2, 2016", "JUL 18, 2016", "JUL 8, 2016", "JUN 14, 2016", "AUG 26, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 5, 2016", "AUG 2, 2016", "JUL 18, 2016", "APR 29, 2016", "APR 29, 2016", "JUN 14, 2016", "JUN 3, 2016", "MAY 19, 2016", "MAY 2, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "JAN 6, 2016", "DEC 29, 2015", "NOV 25, 2015", "NOV 22, 2015", "NOV 4, 2015", "OCT 31, 2015", "JAN 13, 2016", "OCT 27, 2015", "OCT 26, 2015", "SEP 21, 2015", "SEP 21, 2015", "SEP 18, 2015", "SEP 18, 2015", "SEP 17, 2015", "OCT 28, 2015", "AUG 21, 2015", "AUG 17, 2015", "JUL 31, 2015", "JUL 16, 2015", "JUL 13, 2015", "JUL 13, 2015", "JUN 17, 2015", "SEP 17, 2015", "AUG 21, 2015", "AUG 17, 2015", "JUL 31, 2015", "JUL 16, 2015", "JUL 13, 2015", "APR 21, 2015", "JUN 2, 2015", "JUN 2, 2015", "JUN 1, 2015", "APR 27, 2015", "APR 24, 2015", "APR 13, 2015", "APR 4, 2015", "APR 3, 2015", "APR 21, 2015", "MAR 31, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 23, 2015", "FEB 7, 2015", "FEB 4, 2015", "APR 1, 2015", "DEC 26, 2014", "DEC 22, 2014", "DEC 19, 2014", "DEC 19, 2014", "NOV 4, 2014", "OCT 24, 2014", "JAN 30, 2015", "JAN 5, 2015", "DEC 26, 2014", "DEC 22, 2014", "DEC 19, 2014", "DEC 19, 2014", "AUG 4, 2014", "AUG 1, 2014", "OCT 21, 2014", "OCT 17, 2014", "SEP 26, 2014", "SEP 21, 2014", "SEP 17, 2014", "APR 25, 2014", "APR 25, 2014", "JUL 31, 2014", "JUL 21, 2014", "APR 17, 2014", "APR 17, 2014", "APR 17, 2014", "APR 16, 2014", "APR 16, 2014", "APR 25, 2014", "APR 10, 2014", "APR 10, 2014", "APR 10, 2014", "FEB 3, 2014", "JAN 31, 2014", "JAN 31, 2014", "JAN 24, 2014", "APR 14, 2014", "DEC 16, 2013", "NOV 12, 2013", "NOV 11, 2013", "NOV 11, 2013", "NOV 6, 2013", "NOV 5, 2013", "NOV 5, 2013", "DEC 31, 2013", "DEC 16, 2013", "NOV 12, 2013", "NOV 11, 2013", "OCT 16, 2013", "OCT 11, 2013", "OCT 11, 2013", "NOV 5, 2013", "AUG 5, 2013", "AUG 5, 2013", "AUG 2, 2013", "AUG 2, 2013", "AUG 2, 2013", "MAY 28, 2013", "MAY 28, 2013", "OCT 1, 2013", "AUG 5, 2013", "AUG 5, 2013", "AUG 2, 2013", "AUG 2, 2013", "FEB 14, 2013", "JAN 28, 2013", "JAN 24, 2013", "APR 29, 2013", "APR 15, 2013", "APR 12, 2013", "MAR 1, 2013", "FEB 25, 2013", "FEB 14, 2013", "JAN 28, 2013", "JAN 24, 2013", "APR 29, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/7-great-biotech-stocks-to-buy-and-hold-now-2020-06-11", "https://www.nasdaq.com/articles/7-cheap-stocks-to-buy-with-great-potential-2020-05-27", "https://www.nasdaq.com/articles/why-immunogen-stock-jumped-today-2020-05-20", "https://www.nasdaq.com/articles/7-biotech-stocks-wall-street-says-will-double-or-more-2020-05-19", "https://www.nasdaq.com/articles/why-immunogen-stock-jumped-today-2020-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-01-2020%3A-imgnsgenmohmglnathx-2020-05-01", "https://www.nasdaq.com/articles/immunogen-inc-imgn-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/why-immunogen-shares-are-sinking-today-2020-02-18", "https://www.nasdaq.com/articles/7-great-biotech-stocks-to-buy-and-hold-now-2020-06-11", "https://www.nasdaq.com/articles/immunogen-beats-expectations-and-fuels-optimism-for-its-lead-drug-candidate-2020-02-14", "https://www.nasdaq.com/articles/whats-behind-immunogens-blowout-q4-results-2020-02-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-14-2020%3A-dxcmimgnplse-2020-02-14", "https://www.nasdaq.com/articles/immunogen-inc-imgn-q4-2019-earnings-call-transcript-2020-02-14", "https://www.nasdaq.com/articles/stock-alert%3A-immunogen-imgn-2020-02-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-14-2020%3A-plse-slgl-imgn-jnj-pfe-abt-mrk-amgn-2020-02-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-17-2019%3A-gskibioimgncfrx-2019-12-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-14-2020%3A-dcphdxcmimgnplse-2020-02-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-17-2019%3A-pti-imgn-bhvn-jnj-pfe-abt-mrk-amgn-2019-12-17", "https://www.nasdaq.com/articles/heres-why-immunogen-jumped-12.4-today-2019-12-04", "https://www.nasdaq.com/articles/why-immunogen-stock-is-crushing-it-today-2019-11-05", "https://www.nasdaq.com/articles/immunogen-stretches-its-cash-in-q3-banking-on-another-chance-for-its-ovarian-cancer-drug", "https://www.nasdaq.com/articles/immunogen-inc-imgn-q3-2019-earnings-call-transcript-2019-11-01", "https://www.nasdaq.com/articles/week-ahead-in-pharma%3A-9-stocks-to-watch-avxl-gmab-arav...-2019-09-21", "https://www.nasdaq.com/articles/immunogen-inc-imgn-q2-2019-earnings-call-transcript-2019-08-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-17-2019%3A-ibioimgncfrx-2019-12-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-02-2019%3A-apha-tndm-imgn-jnj-pfe-abt-mrk-amgn-2019-08-02", "https://www.nasdaq.com/articles/why-childrens-place-agilent-technologies-and-immunogen-slumped-today-2019-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-15-2019%3A-abbvacbacb.toecorimgn-2019-05-15", "https://www.nasdaq.com/articles/mid-afternoon-market-update%3A-global-eagle-entertainment-surges-after-q1-results-immunogen", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-15-2019%3A-ecor-acb-imgn-2019-05-15", "https://www.nasdaq.com/articles/mid-day-market-update%3A-dow-rises-over-100-points-sunworks-falls-following-q1-results-2019", "https://www.nasdaq.com/articles/mid-morning-market-update%3A-markets-mostly-lower-macys-earnings-top-estimates-2019-05-15", "https://www.nasdaq.com/articles/what-youll-want-to-know-about-immunogens-q2-results-2019-08-02", "https://www.nasdaq.com/articles/immunogen-inc-imgn-q1-2019-earnings-call-transcript-2019-05-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-03-2019%3A-xray-azn-imgn-jnj-pfe-abt-mrk-amgn-2019-05-03", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-imgn-fslr-apc-2019-05-01", "https://www.nasdaq.com/articles/immunogen-stock-trouble-going-earnings-2019-04-15", "https://www.nasdaq.com/articles/immunogen-stock-trouble-going-earnings-2019-04-15-0", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-imgn-spwr-mmm-2019-04-12", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-imgn-spwr-mmm-2019-04-12-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-15-2019%3A-imgn-a-acbi-jnj-pfe-abt-mrk-amgn-2019-05-15", "https://www.nasdaq.com/articles/heres-why-immunogen-tumbled-43-march-2019-04-08-0", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-immunogen-imgn-stock-2019-03-12", "https://www.nasdaq.com/articles/immunogen-imgn-down-50.2-since-last-earnings-report%3A-can-it-rebound-2019-03-10", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biib-to-acquire-nightstar-other-pipeline-news-more-2019-03-06", "https://www.nasdaq.com/articles/immunogen-ovarian-cancer-drug-fails-in-phase-iii-stock-sinks-2019-03-04", "https://www.nasdaq.com/articles/after-hours-most-active-mar-4-2019-lthm-lly-atvi-bac-s-ohi-ge-gild-cmcsa-imgn-aapl-sgms", "https://www.nasdaq.com/articles/why-immunogen-stock-crashing-today-2019-03-01", "https://www.nasdaq.com/articles/heres-why-immunogen-tumbled-43-march-2019-04-08", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-foot-locker-beats-q4-estimates-2019-03-01", "https://www.nasdaq.com/articles/health-care-sector-update-03012019-imgn-mrsn-pbyi-jnj-pfe-mrk-abt-amgn-2019-03-01", "https://www.nasdaq.com/articles/pre-market-most-active-mar-1-2019-imgn-grpn-gps-fl-amd-sqqq-ge-eric-qqq-chk-vips-nio-2019", "https://www.nasdaq.com/articles/immunogen-drug-fails-cancer-study-shares-slide-40-pct-2019-03-01", "https://www.nasdaq.com/articles/health-care-sector-update-03012019-biomrsnpbyiimgn-2019-03-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-25-nutanix-shares-plunge-weak-forecast-2019-03", "https://www.nasdaq.com/articles/health-care-sector-update-03012019-mrsnpbyiimgn-2019-03-01", "https://www.nasdaq.com/articles/mid-day-market-update-puma-biotechnology-climbs-following-strong-q4-results-intrexon", "https://www.nasdaq.com/articles/immunogen-still-waiting-take-its-leap-forward-2019-02-12", "https://www.nasdaq.com/articles/immunogen-imgn-beats-on-earnings-sales-in-q4-shares-up-2019-02-11", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-immunogen-imgn-stock-2019-02-11", "https://www.nasdaq.com/articles/immunogen-imgn-q4-2018-earnings-conference-call-transcript-2019-02-08", "https://www.nasdaq.com/articles/immunogen-imgn-reports-q4-loss-tops-revenue-estimates-2019-02-08", "https://www.nasdaq.com/articles/earnings-reaction-history-immunogen-inc-273-follow-through-indicator-57-sensitive-2019-02", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-vicr-imgn-ttd-2019-02-08", "https://www.nasdaq.com/articles/why-immunogen-tumbled-203-today-2019-02-27", "https://www.nasdaq.com/articles/pre-market-most-active-feb-4-2019-imgn-fold-odp-unm-psx-xog-mtor-ely-acb-bc-eols-celg-2019", "https://www.nasdaq.com/articles/earnings-preview%3A-immunogen-imgn-q4-earnings-expected-to-decline-2019-02-01", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-msft-eght-imgn-2019-01-29", "https://www.nasdaq.com/articles/after-hours-most-active-jan-8-2019-infn-imgn-cmcsa-jd-msft-celg-2019-01-08", "https://www.nasdaq.com/articles/why-immunogen-jumped-today-2019-01-07", "https://www.nasdaq.com/articles/after-hours-most-active-jan-2-2019-imgn-msft-fold-qqq-ebay-xog-2019-01-02", "https://www.nasdaq.com/articles/why-immunogen-shot-13-today-2018-12-26", "https://www.nasdaq.com/articles/why-immunogen-jumped-almost-14-today-2019-02-06", "https://www.nasdaq.com/articles/immunogen-imgn-down-7.2-since-last-earnings-report%3A-can-it-rebound-2018-12-02", "https://www.nasdaq.com/articles/apple-falls-unitedhealth-gains-and-more-morning-movers-2018-11-27", "https://www.nasdaq.com/articles/immunogen-waits-leap-forward-2018-11-09", "https://www.nasdaq.com/articles/heres-why-immunogen-shares-lost-427-october-2018-11-07", "https://www.nasdaq.com/articles/heres-why-immunogen-closed-almost-12-wednesday-2018-11-07", "https://www.nasdaq.com/articles/immunogen-imgn-beats-on-earnings-in-q3-lowers-guidance-2018-11-05", "https://www.nasdaq.com/articles/immunogen-inc-imgn-q3-2018-earnings-conference-call-transcript-2018-11-02", "https://www.nasdaq.com/articles/roches-kadcyla-halves-death-risk-in-breast-cancer-study-2018-12-06", "https://www.nasdaq.com/articles/immunogen-imgn-q3-earnings-preview%3A-what-to-look-out-for-2018-10-26", "https://www.nasdaq.com/articles/heres-why-immunogen-fell-today-2018-10-22", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-dwdp-ip-imgn-2018-10-09", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-immunogen-imgn-stock-2018-10-08", "https://www.nasdaq.com/articles/why-immunogen-inc-dropped-8-today-2018-10-05", "https://www.nasdaq.com/articles/why-immunogen-inc-fell-106-thursday-2018-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-09072018-imgnnvusadxs-2018-09-07", "https://www.nasdaq.com/articles/earnings-reaction-history-immunogen-inc-273-follow-through-indicator-54-sensitive-2018-11", "https://www.nasdaq.com/articles/immunogen-imgn-q3-earnings-preview%3A-what-to-look-out-for-2018-10-26", "https://www.nasdaq.com/articles/immunogen-imgn-q2-earnings-and-revenues-miss-estimates-2018-07-30", "https://www.nasdaq.com/articles/immunogen-imgn-q2-loss-wider-revenues-miss-2018-07-27", "https://www.nasdaq.com/articles/whats-in-store-for-immunogen-imgn-this-earnings-season-2018-07-25", "https://www.nasdaq.com/articles/heres-why-immunogen-fell-151-june-2018-07-13", "https://www.nasdaq.com/articles/interesting-imgn-put-and-call-options-august-17th-2018-07-02", "https://www.nasdaq.com/articles/health-care-sector-update-09072018-opkimgnnvusadxs-2018-09-07", "https://www.nasdaq.com/articles/immunogens-lead-candidate-gets-fast-track-for-ovarian-cancer-2018-06-19", "https://www.nasdaq.com/articles/brian-bolan-show-2018-06-14", "https://www.nasdaq.com/articles/health-care-sector-update-06072018-mrk-asnd-pti-imgn-mdgl-2018-06-07", "https://www.nasdaq.com/articles/heres-why-immunogen-inc-fell-92-today-2018-06-07", "https://www.nasdaq.com/articles/health-care-sector-update-06072018-agnimgnmrkptivrxvrxto-2018-06-07", "https://www.nasdaq.com/articles/health-care-sector-update-06072018-imgnmrkptivrxvrxto-2018-06-07", "https://www.nasdaq.com/articles/why-is-immunogen-imgn-up-4.2-since-its-last-earnings-report-2018-06-04", "https://www.nasdaq.com/articles/better-buy-exelixis-inc-vs-immunogen-inc-2018-06-26", "https://www.nasdaq.com/articles/immunogen-presses-forward-2018-05-08", "https://www.nasdaq.com/articles/immunogen-imgn-q1-loss-wider-than-expected-revenues-beat-2018-05-07", "https://www.nasdaq.com/articles/immunogen-imgn-q1-loss-wider-revenues-beat-2018-05-04", "https://www.nasdaq.com/articles/whats-in-store-for-immunogen-imgn-this-earnings-season-2018-04-30", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-rise-today-2018-04-27", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-immunogen-imgn-stock-2018-04-18", "https://www.nasdaq.com/articles/fast-pipeline-progress-pushes-immunogen-above-150-in-a-year-2018-04-02", "https://www.nasdaq.com/articles/why-immunogen-jumped-higher-today-2018-05-31", "https://www.nasdaq.com/articles/2-longs-2-shorts-watch-2018-03-14", "https://www.nasdaq.com/articles/commit-buy-immunogen-8-earn-316-annualized-using-options-2018-03-12", "https://www.nasdaq.com/articles/first-week-october-19th-options-trading-immunogen-imgn-2018-02-23", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-02-17", "https://www.nasdaq.com/articles/can-immunogens-key-ovarian-cancer-candidate-drive-growth-2018-02-14", "https://www.nasdaq.com/articles/immunogen-moves-one-foot-forward-2018-02-13", "https://www.nasdaq.com/articles/whats-behind-immunogen-incs-brief-dip-tuesday-2018-02-13", "https://www.nasdaq.com/articles/what-knocked-immunogen-inc-down-15-tuesday-2018-03-28", "https://www.nasdaq.com/articles/why-immunogen-jumped-higher-today-2018-02-12", "https://www.nasdaq.com/articles/immunogen-imgn-q4-loss-wider-revenues-rise-y-y-2018-02-09", "https://www.nasdaq.com/articles/earnings-reaction-history-immunogen-inc-200-follow-through-indicator-50-sensitive-2018-02", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-immunogen-imgn-this-earnings-season-2018-02-08", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-immunogen-imgn-in-q4-earnings-2018-02-05", "https://www.nasdaq.com/articles/why-immunogen-inc-pulled-back-today-2018-02-05", "https://www.nasdaq.com/articles/immunogen-imgn-soars%3A-stock-adds-10.3-in-session-2018-02-01", "https://www.nasdaq.com/articles/immunogen-imgn-q4-loss-wider-than-expected-revenues-grow-2018-02-12", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-tuesday-and-holding-steady-2018-01-11", "https://www.nasdaq.com/articles/immunogen-starts-phase-i-study-on-leukemia-candidate-imgn632-2018-01-05", "https://www.nasdaq.com/articles/immunogen-imgn-soars-above-200-this-year%3A-heres-why-2017-12-29", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-12-13", "https://www.nasdaq.com/articles/health-care-sector-update-12112017-vstm-mrk-ions-gild-imgn-juno-celg-regn-bivv-2017-12-11", "https://www.nasdaq.com/articles/5-cheap-biotech-stocks-snag-bounce-2017-12-08", "https://www.nasdaq.com/articles/why-is-immunogen-imgn-stock-up-more-than-150-this-year-2017-11-27", "https://www.nasdaq.com/articles/heres-whats-lifting-immunogen-inc-shares-today-2018-01-31", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-jazz-q3-earnings-top-2017-view-cut-2017-11-08", "https://www.nasdaq.com/articles/big-reason-immunogen-inc-shed-24-its-value-october-2017-11-07", "https://www.nasdaq.com/articles/immunogen-imgn-q3-loss-wider-than-expected-cash-view-up-2017-11-06", "https://www.nasdaq.com/articles/pre-market-most-active-nov-3-2017-p-aapl-teva-sbux-bac-cbl-imgn-qqq-vale-tvix-twtr-mu-2017", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-q3-loss-2017-11-03", "https://www.nasdaq.com/articles/should-you-buy-immunogen-imgn-ahead-of-earnings-2017-11-02", "https://www.nasdaq.com/articles/why-immunogen-inc-got-burned-ash-today-2017-11-01", "https://www.nasdaq.com/articles/immunogen-inc-moves-forward-2017-11-09", "https://www.nasdaq.com/articles/can-immunogens-key-pipeline-cancer-candidate-drive-growth-2017-10-19", "https://www.nasdaq.com/articles/immunogen-to-push-leukemia-candidate-into-phase-i-trial-2017-10-17", "https://www.nasdaq.com/articles/health-care-sector-update-10162017-imgn-2017-10-16", "https://www.nasdaq.com/articles/pre-market-most-active-oct-6-2017-nly-sncr-imgn-bac-mnkd-qqq-eric-tvix-azn-bti-sny-baba", "https://www.nasdaq.com/articles/why-immunogen-inc-dropped-today-2017-10-05", "https://www.nasdaq.com/articles/2-stocks-move-after-hours-trading-2017-10-04", "https://www.nasdaq.com/articles/better-buy-exelixis-inc-vs-immunogen-inc-2017-09-30", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-immunogen-imgn-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/why-shares-immunogen-inc-sank-today-2017-09-12", "https://www.nasdaq.com/articles/tuesday-sector-laggards-electric-utilities-biotechnology-stocks-2017-09-12", "https://www.nasdaq.com/articles/5-key-things-you-should-watch-jazz-pharmaceuticals-2017-09-07", "https://www.nasdaq.com/articles/bull-day-jazz-pharmaceuticals-jazz-2017-09-05", "https://www.nasdaq.com/articles/immunogen-imgn-up-17.7-since-earnings-report%3A-can-it-continue-2017-08-31", "https://www.nasdaq.com/articles/immunogen-inks-deal-with-jazz-pharma-to-develop-adc-molecule-2017-08-30", "https://www.nasdaq.com/articles/immunogen-imgn-in-focus%3A-stock-moves-17.3-higher-2017-08-30", "https://www.nasdaq.com/articles/immunogen-running-out-steam-or-taking-breather-2017-09-16", "https://www.nasdaq.com/articles/why-shares-immunogen-inc-sank-today-2017-09-12", "https://www.nasdaq.com/articles/health-care-sector-update-08292017-jnj-pfe-abt-mrk-amgn-imgn-etrm-2017-08-29", "https://www.nasdaq.com/articles/why-movado-group-catalent-and-immunogen-jumped-today-2017-08-29", "https://www.nasdaq.com/articles/health-care-sector-update-08292017-imgnjazzjunoacor-2017-08-29", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-08-29", "https://www.nasdaq.com/articles/after-hours-most-active-aug-24-2017-msft-lyg-csco-mu-bac-hpq-baba-tgt-myl-imgn-esv-acwi", "https://www.nasdaq.com/articles/why-investors-bid-immunogen-inc-almost-12-today-2017-08-30", "https://www.nasdaq.com/articles/stocks-snap-3-day-losing-streak-2017-08-14", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-xme-2017-08-11", "https://www.nasdaq.com/articles/friday-sector-leaders-computer-peripherals-biotechnology-stocks-2017-08-11", "https://www.nasdaq.com/articles/heres-what-pushed-immunogen-inc-stock-165-lower-july-2017-08-02", "https://www.nasdaq.com/articles/immunogen-inc-earnings-what-goes-must-come-down-2017-07-31", "https://www.nasdaq.com/articles/immunogen-imgn-q2-loss-narrows-sales-cash-outlook-up-2017-07-31", "https://www.nasdaq.com/articles/mid-day-market-update-boston-beer-surges-earnings-beat-destination-maternity-shares-slide", "https://www.nasdaq.com/articles/whats-retailer-do-2017-08-16", "https://www.nasdaq.com/articles/stocks-snap-3-day-losing-streak-2017-08-14", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-xme-2017-08-11", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-07-24", "https://www.nasdaq.com/articles/monday-sector-leaders-biotechnology-drugs-2017-07-24", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-immunogen-imgn-in-q2-earnings-2017-07-21", "https://www.nasdaq.com/articles/can-immunogens-lead-pipeline-cancer-candidate-boost-growth-2017-07-13", "https://www.nasdaq.com/articles/heres-why-immunogen-inc-shares-exploded-54-higher-june-2017-07-10", "https://www.nasdaq.com/articles/immunogen-imgn-reports-narrower-expected-q2-loss-2017-07-28", "https://www.nasdaq.com/articles/why-shares-immunogen-inc-shot-today-2017-07-28", "https://www.nasdaq.com/articles/four-stocks-breaking-out-2017-07-25", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-07-24", "https://www.nasdaq.com/articles/monday-sector-leaders-biotechnology-drugs-2017-07-24", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-immunogen-imgn-in-q2-earnings-2017-07-21", "https://www.nasdaq.com/articles/immunogen-imgn-jumps%3A-stock-rises-10.4-2017-06-21", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-second-day-row-2017-06-21", "https://www.nasdaq.com/articles/health-care-sector-update-07062017-imgnbgnecelgeglt-2017-07-06", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-monday-2017-06-26", "https://www.nasdaq.com/articles/health-care-sector-update-06262017-imgnsrneneot-2017-06-26", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-lennar-tops-q2-expectations-2017-06-20", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-06-20", "https://www.nasdaq.com/articles/mid-afternoon-market-update-fang-drops-after-q1-results-invivo-therapeutics-shares-surge", "https://www.nasdaq.com/articles/tuesday-sector-leaders-biotechnology-drugs-2017-06-20", "https://www.nasdaq.com/articles/why-is-immunogen-imgn-stock-up-131-this-year-2017-06-15", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-3-la-z-boy-shares-gain-earnings-beat-2017-06-21", "https://www.nasdaq.com/articles/immunogen-imgn-up-21.2-since-earnings-report%3A-can-it-continue-2017-06-07", "https://www.nasdaq.com/articles/3-stocks-exelixis-return-potential-2017-06-05", "https://www.nasdaq.com/articles/after-hours-most-active-may-24-2017-intc-pfe-wy-f-win-mro-oas-jcp-msft-imgn-brcd-ebay-2017", "https://www.nasdaq.com/articles/immunogen-imgn-shows-strength%3A-stock-up-14.2-higher-2017-05-19", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-wal-mart-profit-tops-estimates-2017-05-18", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-05-18", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-flying-high-today-2017-05-15", "https://www.nasdaq.com/articles/short-investing-cash-these-5-stocks-are-big-2017-2017-06-12", "https://www.nasdaq.com/articles/immunogen-imgn-posts-narrower-than-expected-loss-in-q1-2017-05-08", "https://www.nasdaq.com/articles/immunogen-imgn-reports-narrower-than-expected-loss-2017-05-05", "https://www.nasdaq.com/articles/whats-in-the-cards-for-allergan-agn-this-earnings-season-2017-05-04", "https://www.nasdaq.com/articles/why-immunogen-imgn-might-surprise-this-earnings-season-2017-05-04", "https://www.nasdaq.com/articles/puma-biotechnology-pbyi-q1-earnings%3A-stock-to-disappoint-2017-05-03", "https://www.nasdaq.com/articles/jazz-pharma-jazz-q1-earnings%3A-stock-likely-to-disappoint-2017-05-03", "https://www.nasdaq.com/articles/whats-in-the-cards-for-inovio-ino-this-earnings-season-2017-05-03", "https://www.nasdaq.com/articles/immunogen-inc-begins-forward-i-investors-wait-2017-05-10", "https://www.nasdaq.com/articles/is-immunogen-imgn-poised-for-a-beat-this-earnings-season-2017-05-02", "https://www.nasdaq.com/articles/can-conatus-pharma-cnat-deliver-a-beat-in-q1-earnings-2017-05-02", "https://www.nasdaq.com/articles/when-will-immunogen-inc-finally-start-making-money-2017-04-27", "https://www.nasdaq.com/articles/why-immunogen-inc-jumped-higher-today-2017-04-20", "https://www.nasdaq.com/articles/why-immunogen-inc-shot-today-2017-04-19", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-jumped-higher-today-2017-04-13", "https://www.nasdaq.com/articles/immunogen-imgn-up-47.2-since-earnings-report%3A-can-it-continue-2017-03-20", "https://www.nasdaq.com/articles/kite-pharma-kite-q1-earnings%3A-is-a-surprise-in-the-cards-2017-05-03", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-dollar-general-beats-q4-expectations-2017-03", "https://www.nasdaq.com/articles/heres-why-immunogen-inc-skyrocketed-45-february-2017-03-09", "https://www.nasdaq.com/articles/3-charts-show-potential-risks-and-rewards-immunogen-inc-stock-2017-03-04", "https://www.nasdaq.com/articles/monday-sector-leaders-music-electronics-stores-biotechnology-stocks-2017-02-27", "https://www.nasdaq.com/articles/why-immunogen-inc-skyrocketed-higher-today-2017-02-27", "https://www.nasdaq.com/articles/immunogen-inc-waiting-move-forward-2017-02-21", "https://www.nasdaq.com/articles/immunogen-posts-wider-than-expected-loss-sales-down-y-y-2017-02-20", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-tiffany-earnings-top-estimates-2017-03-17", "https://www.nasdaq.com/articles/earnings-reaction-history-immunogen-inc-333-follow-through-indicator-57-sensitive-2017-02", "https://www.nasdaq.com/articles/whats-in-store-for-immunogen-imgn-this-earnings-season-2017-02-13", "https://www.nasdaq.com/articles/immunogen-doses-first-patient-in-ovarian-cancer-drug-study-2017-01-27", "https://www.nasdaq.com/articles/wednesday-sector-leaders-biotechnology-music-electronics-stores-2017-01-04", "https://www.nasdaq.com/articles/why-immnogen-inc-jumped-higher-today-2017-01-04", "https://www.nasdaq.com/articles/why-immunogen-inc-shares-rocketed-higher-29-2016-12-30", "https://www.nasdaq.com/articles/immunogen%3A-phase-i-data-on-ovarian-cancer-drug-published-2016-12-29", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-loss-2017-02-17", "https://www.nasdaq.com/articles/earnings-reaction-history-immunogen-inc-333-follow-through-indicator-57-sensitive-2017-02", "https://www.nasdaq.com/articles/whats-in-store-for-immunogen-imgn-this-earnings-season-2017-02-13", "https://www.nasdaq.com/articles/immunogen-doses-first-patient-in-ovarian-cancer-drug-study-2017-01-27", "https://www.nasdaq.com/articles/wednesday-sector-leaders-biotechnology-music-electronics-stores-2017-01-04", "https://www.nasdaq.com/articles/amerisourcebergen-abc-q3-earnings%3A-will-it-disappoint-2016-10-27", "https://www.nasdaq.com/articles/peek-into-drug-stocks-earnings-on-oct-28%3A-abbv-imgn-2016-10-27", "https://www.nasdaq.com/articles/big-changes-bioshares-biotech-etfs-whos-whos-out-2016-12-19", "https://www.nasdaq.com/articles/glaxosmithkline-gsk-q3-earnings%3A-whats-in-the-cards-2016-10-21", "https://www.nasdaq.com/articles/mckesson-mck-q2-earnings%3A-stock-likely-to-disappoint-2016-10-21", "https://www.nasdaq.com/articles/express-scripts-esrx-q3-earnings%3A-whats-in-the-cards-2016-10-20", "https://www.nasdaq.com/articles/alexion-alxn-q3-earnings%3A-can-the-stock-pull-a-surprise-2016-10-20", "https://www.nasdaq.com/articles/novartis-nvs-q3-earnings%3A-stock-to-beat-estimates-again-2016-10-20", "https://www.nasdaq.com/articles/vertex-vrtx-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-20", "https://www.nasdaq.com/articles/immunogen-to-cut-workforce-by-17-for-long-term-growth-2016-10-03", "https://www.nasdaq.com/articles/whats-ahead-for-immunogen-imgn-this-earnings-season-2016-10-24", "https://www.nasdaq.com/articles/immunogen-inc-gets-fda-green-light-its-trial-design-2016-08-09", "https://www.nasdaq.com/articles/these-2-lingering-issues-pushed-immunogen-inc-lower-10-july-2016-08-08", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-loss-in-q4-2016-08-05", "https://www.nasdaq.com/articles/will-immunogen-imgn-disappoint-again-on-q4-earnings-2016-08-02", "https://www.nasdaq.com/articles/why-immunogen-inc-bounded-higher-today-2016-07-18", "https://www.nasdaq.com/articles/immunogen-inc-shed-45-its-value-june-can-it-recover-2016-07-08", "https://www.nasdaq.com/articles/why-immunogen-imgn-stock-down-today-2016-06-14", "https://www.nasdaq.com/articles/beaten-down-biotech-could-return-1500-heres-why-i-wont-buy-it-2016-08-26", "https://www.nasdaq.com/articles/immunogen-inc-gets-fda-green-light-its-trial-design-2016-08-09", "https://www.nasdaq.com/articles/these-2-lingering-issues-pushed-immunogen-inc-lower-10-july-2016-08-08", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-loss-in-q4-2016-08-05", "https://www.nasdaq.com/articles/will-immunogen-imgn-disappoint-again-on-q4-earnings-2016-08-02", "https://www.nasdaq.com/articles/why-immunogen-inc-bounded-higher-today-2016-07-18", "https://www.nasdaq.com/articles/why-immunogen-inc-was-down-today-hint-it-wasnt-earnings-2016-04-29", "https://www.nasdaq.com/articles/notable-friday-option-activity-met-gs-imgn-2016-04-29", "https://www.nasdaq.com/articles/why-immunogen-inc-noted-lower-price-today-2016-06-14", "https://www.nasdaq.com/articles/moving-forward-sends-immunogen-inc-backwards-may-2016-06-03", "https://www.nasdaq.com/articles/immunogen-announces-phase-i-cohort-ovarian-cancer-data-2016-05-19", "https://www.nasdaq.com/articles/immunogen-imgn-posts-wider-than-expected-q3-loss-2016-05-02", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-exxon-mobil-profit-tops-estimates-2016-04-29", "https://www.nasdaq.com/articles/immunogen-imgn-posts-wider-than-expected-q3-loss-2016-04-29", "https://www.nasdaq.com/articles/why-immunogen-inc-was-down-today-hint-it-wasnt-earnings-2016-04-29", "https://www.nasdaq.com/articles/mid-afternoon-market-update-nasdaq-down-over-1-skywest-shares-jump-earnings-beat-2016-04", "https://www.nasdaq.com/articles/imgn-makes-notable-cross-below-critical-moving-average-2016-01-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-alps-medical-breakthroughs-etf-anacor-pharmaceuticals", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-deere-profit-tops-views-2015-11-25", "https://www.nasdaq.com/articles/heres-why-immunomedics-stock-skyrocketed-higher-october-2015-11-22", "https://www.nasdaq.com/articles/commit-buy-immunogen-9-earn-124-annualized-using-options-2015-11-04", "https://www.nasdaq.com/articles/immunogen-inc-pushes-its-pipeline-forward-2015-10-31", "https://www.nasdaq.com/articles/why-biomarin-pharmaceutical-inc-ionis-pharmaceuticals-inc-and-immunogen-inc-got-clobbered", "https://www.nasdaq.com/articles/immunogens-imgn-q1fy16-loss-wider-than-expected-2015-10-27", "https://www.nasdaq.com/articles/what-awaits-immunogen-imgn-this-earnings-season-2015-10-26", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-lennar-tops-q3-views-2015-09-21", "https://www.nasdaq.com/articles/why-immunogen-fell-15-today-2015-09-21", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-xbi-2015-09-18", "https://www.nasdaq.com/articles/why-immunogen-shares-are-falling-today-2015-09-18", "https://www.nasdaq.com/articles/why-immunogens-shares-soared-13-higher-today-2015-09-17", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-loss-in-q1-2015-10-28", "https://www.nasdaq.com/articles/why-shares-immunogen-inc-were-big-today-2015-08-21", "https://www.nasdaq.com/articles/immunogen-inc-finally-targeting-strong-returns-2015-08-17", "https://www.nasdaq.com/articles/immunogen-back-development-stage-biotech-2015-07-31", "https://www.nasdaq.com/articles/immunogen-climbing-higher-again-2015-07-16", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-gdx-2015-07-13", "https://www.nasdaq.com/articles/immunogen-incs-shares-jumped-another-15-today-2015-07-13", "https://www.nasdaq.com/articles/5-healthy-stocks-top-biotech-etf-etf-news-and-commentary-2015-06-17", "https://www.nasdaq.com/articles/thursdays-etf-movers-xbi-gxc-2015-09-17", "https://www.nasdaq.com/articles/why-shares-immunogen-inc-were-big-today-2015-08-21", "https://www.nasdaq.com/articles/immunogen-inc-finally-targeting-strong-returns-2015-08-17", "https://www.nasdaq.com/articles/immunogen-back-development-stage-biotech-2015-07-31", "https://www.nasdaq.com/articles/immunogen-climbing-higher-again-2015-07-16", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-gdx-2015-07-13", "https://www.nasdaq.com/articles/will-alexions-alxn-soliris-drive-q1-earnings-beat-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/strength-seen-in-immunogen-imgn%3A-stock-soars-71.9-tale-of-the-tape-2015-06-02", "https://www.nasdaq.com/articles/immunogen-surges-on-positive-ovarian-cancer-study-data-analyst-blog-2015-06-02", "https://www.nasdaq.com/articles/why-immunogen-incs-stock-soared-today-2015-06-01", "https://www.nasdaq.com/articles/why-immunogen-inc-shares-tumbled-today-2015-04-27", "https://www.nasdaq.com/articles/best-pure-play-investment-cancer-drugs-2015-04-19", "https://www.nasdaq.com/articles/will-pharmaceutical-sales-drive-jj-jnj-earnings-again-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/1-small-cap-biotech-stock-buy-and-hold-next-10-years-2015-04-04", "https://www.nasdaq.com/articles/5-promising-biotech-stocks-under-10-2015-04-03", "https://www.nasdaq.com/articles/is-abbvie-abbv-set-to-top-1q-earnings-on-humira-hcv-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/why-immunogen-inc-skyrocketing-today-2015-03-31", "https://www.nasdaq.com/articles/why-immunogen-inc-soaring-higher-today-2015-03-23", "https://www.nasdaq.com/articles/futures-cautious-greece-oil-and-economic-calendar-weigh-equities-2015-03-23", "https://www.nasdaq.com/articles/pre-market-most-active-mar-23-2015-sto-gsk-gild-aapl-vrtx-imgn-rdsb-qqq-fb-rdsa-sdrl-nvs", "https://www.nasdaq.com/articles/health-care-sector-update-03232015-imgncapnmeip-2015-03-23", "https://www.nasdaq.com/articles/case-you-missed-it-researchers-may-have-discovered-new-method-treat-cancer-2015-02-07", "https://www.nasdaq.com/articles/why-immunogen-inc-shares-rocketed-higher-25-january-2015-02-04", "https://www.nasdaq.com/articles/immunogen-imgn-in-focus%3A-stock-rises-5.1-in-session-tale-of-the-tape-2015-04-01", "https://www.nasdaq.com/articles/3-value-stocks-near-52-week-lows-worth-buying-2014-12-26", "https://www.nasdaq.com/articles/immunogen-roches-kadcyla-fails-in-study-shares-plunge-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/pre-market-most-active-dec-19-2014-ally-bbry-bp-avnr-tnk-pbr-orex-bhp-sdrl-qqq-aapl-imgn", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-was-throttled-2014-12-19", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-plunged-13-october-2014-11-04", "https://www.nasdaq.com/articles/immunogen-inc-pushes-forward-2014-10-24", "https://www.nasdaq.com/articles/immunogen-inc-gets-black-accounting-wise-2015-01-30", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-was-decimated-december-2015-01-05", "https://www.nasdaq.com/articles/3-value-stocks-near-52-week-lows-worth-buying-2014-12-26", "https://www.nasdaq.com/articles/immunogen-roches-kadcyla-fails-in-study-shares-plunge-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/pre-market-most-active-dec-19-2014-ally-bbry-bp-avnr-tnk-pbr-orex-bhp-sdrl-qqq-aapl-imgn", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-was-throttled-2014-12-19", "https://www.nasdaq.com/articles/immunogen-q4-loss-narrower-than-expected-provides-guidance-analyst-blog-2014-08-04", "https://www.nasdaq.com/articles/3-beaten-down-stocks-worth-buying-2014-08-01", "https://www.nasdaq.com/articles/immunogen-imgn-in-focus%3A-stock-rallies-14-tale-of-the-tape-2014-10-21", "https://www.nasdaq.com/articles/3-value-stocks-near-52-week-lows-worth-buying-2014-10-17", "https://www.nasdaq.com/articles/first-week-imgn-november-22nd-options-trading-2014-09-26", "https://www.nasdaq.com/articles/breast-cancer-occurs-most-often-these-5-states-2014-09-21", "https://www.nasdaq.com/articles/why-immunogen-inc-stock-crashed-22-2014-2014-09-17", "https://www.nasdaq.com/articles/synergy-pharmaceuticals-sgyp-jumps%3A-stock-up-10.9-tale-of-the-tape-2014-04-25", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-lower-pre-market-immunogens-q3-net-loss-widens-year", "https://www.nasdaq.com/articles/why-immunogen-imgn-might-surprise-this-earnings-season-tale-of-the-tape-2014-07-31", "https://www.nasdaq.com/articles/immunogen-imgn-soars%3A-stock-up-8.8-tale-of-the-tape-2014-07-21", "https://www.nasdaq.com/articles/strength-seen-in-apricus-biosciences-apri%3A-stock-soars-18.9-tale-of-the-tape-2014-04-17", "https://www.nasdaq.com/articles/immunogen-inc.-imgn-in-focus%3A-stock-rallies-11-tale-of-the-tape-2014-04-17", "https://www.nasdaq.com/articles/zogenix-shares-soar-on-massachusetts-developments-analyst-blog-2014-04-17", "https://www.nasdaq.com/articles/wednesday-sector-leaders-biotechnology-rubber-plastics-2014-04-16", "https://www.nasdaq.com/articles/wednesdays-etf-movers-fbt-gdx-2014-04-16", "https://www.nasdaq.com/articles/sector-update-healthcares-2014-04-25", "https://www.nasdaq.com/articles/pacira-prices-offering-shares-soar-analyst-blog-2014-04-10", "https://www.nasdaq.com/articles/immunogen-up-on-positive-pipeline-data-analyst-blog-2014-04-10", "https://www.nasdaq.com/articles/regulatory-update-from-forest-labs-analyst-blog-2014-04-10", "https://www.nasdaq.com/articles/immunogens-q2fy14-earnings-surpass-expectations-analyst-blog-2014-02-03", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-immunogen-4-q4-results-2014-01-31", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-31-1", "https://www.nasdaq.com/articles/earnings-reaction-history-immunogen-inc-429-follow-through-indicator-58-sensitive-2014-01", "https://www.nasdaq.com/articles/pharmacyclics-pcyc-crumbles%3A-stock-falls-by-7.7-tale-of-the-tape-2014-04-14", "https://www.nasdaq.com/articles/immunogen-amends-lilly-agreement-analyst-blog-2013-12-16", "https://www.nasdaq.com/articles/immunogen-rises-on-licensing-deal-analyst-blog-2013-11-12", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-progenics-reports-better-expected-net", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-11-11-1", "https://www.nasdaq.com/articles/immunogen-shares-fall-on-trial-halt-analyst-blog-2013-11-06", "https://www.nasdaq.com/articles/mid-afternoon-market-update-marvell-rises-kkr-stake-while-orbitz-gives-last-weeks-gains", "https://www.nasdaq.com/articles/healthcare-stocks-mostly-retreat-immunogen-falls-more-20-after-shelving-influenza-drug", "https://www.nasdaq.com/articles/biocryst-confirms-funding-for-bcx4430-analyst-blog-2013-12-31", "https://www.nasdaq.com/articles/immunogen-amends-lilly-agreement-analyst-blog-2013-12-16", "https://www.nasdaq.com/articles/immunogen-rises-on-licensing-deal-analyst-blog-2013-11-12", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-progenics-reports-better-expected-net", "https://www.nasdaq.com/articles/immunogen-in-licensing-deals-analyst-blog-2013-10-16", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-higher-immunogen-6-licensing-novartis-2013-10-11", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-11", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-11-05-1", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-immunogen-analyst-blog-2013-08-05", "https://www.nasdaq.com/articles/company-news-for-august-5-2013-corporate-summary-2013-08-05", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-flat-pre-market-immunogen-hits-new-52-week-high-q2-results", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-02", "https://www.nasdaq.com/articles/trade-earnings-immunogen-inc-2013-08-02", "https://www.nasdaq.com/articles/gurufocus-reports-dividend-growers-may-17-24-2013-05-28", "https://www.nasdaq.com/articles/murray-stahls-64-billion-horizon-kinetics-sells-out-six-companies-first-quarter-2013-05-28", "https://www.nasdaq.com/articles/sector-update-biotechnology-stocks-showing-way-nasdaq-2013-10-01", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-immunogen-analyst-blog-2013-08-05", "https://www.nasdaq.com/articles/company-news-for-august-5-2013-corporate-summary-2013-08-05", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-flat-pre-market-immunogen-hits-new-52-week-high-q2-results", "https://www.nasdaq.com/articles/fda-approves-roches-kadcyla-analyst-blog-2013-02-25", "https://www.nasdaq.com/articles/immunogen-progresses-with-imgn901-analyst-blog-2013-02-14", "https://www.nasdaq.com/articles/wider-loss-at-immunogen-analyst-blog-2013-01-28", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-25-2013-pg-hon-hal-kmb-cov-wy-osk-pb-moga-imgn-aco-cmco", "https://www.nasdaq.com/articles/immunogen-narrows-loss-analyst-blog-2013-04-29", "https://www.nasdaq.com/articles/immunogen-to-focus-on-pipeline-analyst-blog-2013-04-15", "https://www.nasdaq.com/articles/market-wrap-friday-april-12-stocks-record-modest-losses-treasuries-surge-and-precious", "https://www.nasdaq.com/articles/roche-teams-up-with-biocare-analyst-blog-2013-03-01", "https://www.nasdaq.com/articles/fda-approves-roches-kadcyla-analyst-blog-2013-02-25", "https://www.nasdaq.com/articles/immunogen-progresses-with-imgn901-analyst-blog-2013-02-14", "https://www.nasdaq.com/articles/wider-loss-at-immunogen-analyst-blog-2013-01-28", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-25-2013-pg-hon-hal-kmb-cov-wy-osk-pb-moga-imgn-aco-cmco", "https://www.nasdaq.com/articles/immunogen-narrows-loss-analyst-blog-2013-04-29"], "Content": []}